Track PURE Bioscience's accounts payable ($720K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (April 2026), PURE shows a accounts payable of $720K. That compares with $800K in the prior-year period — down 10.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PURE's accounts payable is now $720K (was $800K) — a 10.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether PURE Bioscience is outperforming or lagging.
Tracking PURE's accounts payable over time shows whether PURE Bioscience is scaling, shrinking, or reshaping that part of the business. The current reading is $720K That compares with $800K in the prior-year period — down 10.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this accounts payable page, Stockcircle has PURE Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $720K) with ownership activity and broader fundamentals.